ICU Medical (NASDAQ:ICUI) Releases FY 2022 Earnings Guidance
ICU Medical (NASDAQ:ICUI) Releases FY 2022 Earnings Guidance
ICU Medical (NASDAQ:ICUI – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $6.20-$6.80 for the period, compared to the consensus estimate of $9.17. The company issued revenue guidance of -.
ICU Medical(纳斯达克代码：ICUI-GET Rating)周二上午发布了2022财年最新收益指引。该公司提供了6.20-6.80美元的每股收益指引，而普遍预期为9.17美元。该公司发布了收入指引-。
ICU Medical Trading Down 0.9 %
ICU医疗降价0.9%
ICUI stock traded down $1.49 during mid-day trading on Tuesday, reaching $155.89. 2,098 shares of the stock traded hands, compared to its average volume of 233,627. The stock's fifty day moving average is $169.16 and its 200-day moving average is $193.86. The company has a current ratio of 2.45, a quick ratio of 1.25 and a debt-to-equity ratio of 0.78. The company has a market cap of $3.73 billion, a P/E ratio of 371.41 and a beta of 0.57. ICU Medical has a 52-week low of $155.34 and a 52-week high of $282.00.
周二午盘交易中，ICUI股价下跌1.49美元，至155.89美元。该股有2,098股易手，而其平均成交量为233,627股。该股的50日移动均线切入位为169.16美元，200日移动均线切入位为193.86美元。该公司的流动比率为2.45，速动比率为1.25，债务权益比率为0.78。该公司市值为37.3亿美元，市盈率为371.41，贝塔系数为0.57.ICU Medical的52周低点为155.34美元，52周高位为282.00美元。
ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 earnings per share for the quarter, missing the consensus estimate of $1.68 by ($0.31). The business had revenue of $561.00 million for the quarter, compared to the consensus estimate of $569.30 million. ICU Medical had a net margin of 0.31% and a return on equity of 6.97%. ICU Medical's revenue was up 74.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.57 EPS. As a group, sell-side analysts expect that ICU Medical will post 5.23 earnings per share for the current year.
ICU Medical(纳斯达克代码：ICUI-GET Rating)最近一次发布季度收益数据是在8月8日星期一。这家医疗器械供应商公布本季度每股收益为1.37美元，低于普遍预期的1.68美元(0.31美元)。该业务本季度的收入为5.61亿美元，而普遍预期为5.693亿美元。ICU Medical的净利润率为0.31%，股本回报率为6.97%。与去年同期相比，ICU Medical的收入增长了74.4%。去年同期，该业务公布的每股收益为1.57美元。卖方分析师预计，作为一个整体，ICU Medical本年度每股收益将达到5.23美元。
Analysts Set New Price Targets
分析师设定新的价格目标
Institutional Inflows and Outflows
机构资金流入和流出
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in ICU Medical by 8.8% in the first quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier's stock worth $472,466,000 after purchasing an additional 171,851 shares during the period. Wellington Management Group LLP lifted its stake in ICU Medical by 71.6% in the 1st quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier's stock valued at $337,542,000 after acquiring an additional 632,609 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of ICU Medical by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 342,453 shares of the medical instruments supplier's stock worth $76,248,000 after purchasing an additional 6,562 shares in the last quarter. Eaton Vance Management raised its stake in ICU Medical by 45.4% in the 1st quarter. Eaton Vance Management now owns 265,343 shares of the medical instruments supplier's stock valued at $59,077,000 after acquiring an additional 82,861 shares during the period. Finally, Northern Trust Corp raised its stake in ICU Medical by 5.7% in the 2nd quarter. Northern Trust Corp now owns 240,230 shares of the medical instruments supplier's stock valued at $39,491,000 after acquiring an additional 12,974 shares during the period. 90.20% of the stock is owned by institutional investors.
一些机构投资者最近改变了他们在该业务中的头寸。先锋集团(Vanguard Group Inc.)在第一季度将其在ICU Medical的头寸增加了8.8%。先锋集团目前持有这家医疗器械供应商2,122,104股股票，价值472,466,000美元，在此期间又购买了171,851股。惠灵顿管理集团LLP在第一季度增持了71.6%的ICU Medical股份。惠灵顿管理集团(Wellington Management Group LLP)现在拥有这家医疗器械供应商1,516,089股股票，价值337,542,000美元，上个季度又收购了632,609股。Dimension Fund Advisors LP在第一季度将其在ICU Medical的股份增加了2.0%。Dimension Fund Advisors LP在上个季度额外购买了6,562股后，现在拥有这家医疗器械供应商价值76,248,000美元的股票342,453股。伊顿·万斯管理公司在第一季度增持了45.4%的ICU医疗股份。伊顿·万斯管理公司在此期间额外收购了82,861股，现在拥有这家医疗器械供应商265,343股股票，价值59,077,000美元。最后，北方信托公司在第二季度将其在ICU Medical的持股比例提高了5.7%。北方信托公司现在拥有240,230股这家医疗器械供应商的股票，价值39,491,000美元，在此期间又购买了12,974股。90.20%的股票由机构投资者持有。
About ICU Medical
关于ICU医疗
(Get Rating)
(获取评级)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
ICU医疗公司及其子公司在全球范围内开发、制造和销售用于输液治疗和危重护理应用的医疗设备。该公司的输液治疗产品包括MicroClave、MicroClave Clear和NanoClave品牌的无针产品；中子导管通畅设备；SwabCap和SwabTip消毒帽；Tego血液透析连接器；ClearGuard HD，血液透析导管的抗菌屏障帽；ChemoClave和ChemoLock封闭式系统传输设备，以及用于制备危险药物的Diana危险药物复合系统。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- Broadcom Bounces From Institutional Bottom
- Affirm is the Underdog Starring in a Spaghetti Western
- Is Autozone A Buy Before Earnings Are Released?
- Is There Value in Verizon Shares at These Levels?
- MarketBeat Podcast: Stock Market, Bad News is Good News
- 免费获取StockNews.com关于ICU医学的研究报告(ICUI)
- 博通从机构底部反弹
- 阿奎姆是意大利西部片中的失败者
- AutoZone是在收益发布之前买入的吗？
- 在这些水平上，Verizon的股价有价值吗？
- 市场Beat播客：股市，坏消息就是好消息
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接受ICU医学日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对ICU医疗及相关公司的最新新闻和分析师评级的每日简要摘要。